Apoptosis of metastatic prostate cancer cells by a combination of cyclin-dependent kinase and AKT inhibitors

The International Journal of Biochemistry & Cell Biology
Subhra MohapatraW Jackson Pledger

Abstract

Effective treatments for advanced prostate cancer are much needed. Toward this goal, we show apoptosis and impaired long-term survival of androgen-independent prostate cancer cells (PC3 and PC3 derivatives) co-treated with the cyclin-dependent kinase (CDK) inhibitor roscovitine and an AKT inhibitor (LY294002 or API-2). Apoptosis of PC3 cells by the drug combination required caspase-9 but not caspase-8 activity and thus is mitochondria-dependent. Roscovitine reduced amounts of the caspase inhibitor XIAP, and API-2 increased amounts of the BH3-only protein Bim. PC3 cells apoptosed when co-treated with API-2 and either cdk9 siRNA, dominant-negative cdk9, or the cdk9 inhibitor DRB; they did not apoptose when co-treated with API-2 and XIAP siRNA. Bax accumulated in mitochondria in response to API-2, whereas release of cytochrome c from mitochondria required both API-2 and roscovitine. We suggest that roscovitine elicits events that activate Bax once it translocates to mitochondria and that inactivation of cdk9 signals these events and the down-regulation of XIAP. Collectively, our data show apoptosis of prostate cancer cells by a drug combination and identify Bax activation as a basis of cooperation.

References

Jan 7, 1998·The Journal of Cell Biology·K G WolterR J Youle
Feb 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·K PodsypaninaR Parsons
Aug 31, 2000·Annual Review of Biochemistry·A StrasserV M Dixit
Dec 6, 2000·Microbiology and Molecular Biology Reviews : MMBR·H Y Chang, X Yang
Jun 21, 2001·Molecular and Cellular Biology·E L SoucieL Z Penn
Feb 14, 2002·The Journal of Biological Chemistry·Fuminori TsurutaYukiko Gotoh
Mar 20, 2002·Nature Reviews. Cancer·B J Feldman, D Feldman
Dec 21, 2002·Molecular Immunology·Christoph Borner
May 10, 2003·The Journal of Biological Chemistry·Chih-Cheng YangChing-Shih Chen
Feb 10, 2004·The Journal of Biological Chemistry·Shyra J GardaiPeter M Henson
May 8, 2004·Biochemical Pharmacology·Edward A MonacoMary Lou Vallano
Jul 30, 2004·Molecular and Cellular Biology·John C WilkinsonColin S Duckett
Jan 12, 2005·The Journal of Biological Chemistry·Meiguo Xin, Xingming Deng
May 11, 2005·Expert Opinion on Investigational Drugs·Peter M Fischer, Athos Gianella-Borradori
Jun 21, 2005·Genes & Development·Anton MeinhartPatrick Cramer
Aug 23, 2005·Nature Cell Biology·Honglai ZhangCun-Yu Wang
Nov 12, 2005·The Journal of Biological Chemistry·Xiao-Jun QiPhilip H Howe
Nov 17, 2005·Oncogene·Pradip K Majumder, William R Sellers
Mar 4, 2006·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Apr 28, 2006·The EMBO Journal·Paulina J DlugoszDavid W Andrews
Jul 26, 2006·Proceedings of the National Academy of Sciences of the United States of America·Cristina Muñoz-PinedoDouglas R Green
Nov 3, 2006·Genes & Development·Hemali P Phatnani, Arno L Greenleaf
Jun 7, 2007·International Journal of Cancer. Journal International Du Cancer·Sanjeev ShuklaSanjay Gupta
Jul 20, 2007·Cancer Research·Michael M Shen, Cory Abate-Shen

❮ Previous
Next ❯

Citations

Jul 31, 2013·Apoptosis : an International Journal on Programmed Cell Death·Ajda Coker GürkanNarçin Palavan-Ünsal
Dec 6, 2011·Cancer Metastasis Reviews·H AntonyA L Munn
Dec 1, 2009·Future Medicinal Chemistry·Józefa Węsierska-GądekVladimír Kryštof
Dec 12, 2013·BMC Complementary and Alternative Medicine·Srilatha BadaboinaByung Yeoup Chung
Aug 12, 2014·Expert Opinion on Investigational Drugs·Carmen CriscitielloGiuseppe Curigliano
Apr 28, 2009·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Paul DentSteven Grant
Jun 27, 2015·Clinical and Experimental Pharmacology & Physiology·Yingxiao LiAkio Inui
May 19, 2011·Molecular Cancer·Xiaoqin WangSubhra Mohapatra
Aug 4, 2016·Apoptosis : an International Journal on Programmed Cell Death·Ozge BerrakNarçin Palavan-Unsal
Sep 2, 2016·Endocrine-related Cancer·Muhammed H RahamanShudong Wang
Feb 20, 2013·Cancer Growth and Metastasis·Stacy L WempeCarlos M Telleria
Jul 20, 2017·Journal of Cellular Biochemistry·Lia Carolina FrancoAntonio Giordano
Mar 3, 2021·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Izabela Szymczak-PajorAgnieszka Śliwińska

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Apoptotic Caspases

Apoptotic caspases belong to the protease enzyme family and are known to play an essential role in inflammation and programmed cell death. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis